Forte Biosciences, Inc. (FBRX)
NASDAQ · Healthcare
Forte Biosciences, Inc. Operating Income 2016–2019
Forte Biosciences, Inc. annual/quarterly operating income history and growth rate from 2016 to 2019. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Forte Biosciences, Inc. operating income for the quarter ending September 30, 2019 was -684000, a 147.93% decrease year-over-year.
- Forte Biosciences, Inc. operating income for the twelve months ending September 30, 2019 was -16.8 M, a 64.01% decrease year-over-year.
- Forte Biosciences, Inc. annual operating income for 2019 was -4.1 M, a 91.14% decrease from 2018.
- Forte Biosciences, Inc. annual operating income for 2018 was -45.9 M, a 21.86% increase from 2017.
- Forte Biosciences, Inc. annual operating income for 2017 was -37.6 M, a 18.74% increase from 2016.
- Forte Biosciences, Inc. annual operating income for 2016 was -31.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Forte Biosciences, Inc. Operating Income — FAQ
Forte Biosciences, Inc. (FBRX) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Forte Biosciences, Inc.'s operating income?
Forte Biosciences, Inc. (FBRX) reported operating income of -$4M for fiscal 2019.
Where can I see FBRX's operating income history?
The chart and table above show Forte Biosciences, Inc.'s operating income by year and by quarter, including the growth rate.